Maryland Oncology Hematology
Annapolis, Maryland, United States
Cancer treatment center in Parole, Maryland
810 Bestgate Rd Suite 400, Annapolis, MD 21401
About Maryland Oncology Hematology
"Today, Maryland Oncology Hematology is the largest independent Medical Oncology and Hematology group in Maryland with 30 physicians practicing in 9 locations across central Maryland. Dedicated to providing the most advanced cancer care availble anywhere in an atmosphere of caring compassion."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Maryland Oncology Hematology
During the past decade, Maryland Oncology Hematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
2001-05-01
Completed
608
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Secondary Prevention of Small Subcortical Strokes Trial
2003-02-01
2012-04-01
Completed
3,020
Glucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients With Knee Osteoarthritis
2000-05-01
2002-12-01
Completed
300
"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects
2005-01-01
2007-05-01
Completed
200
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
2003-09-19
2013-10-01
Completed
1,925
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Maryland Oncology Hematology
According to Clinical.Site data, the most researched conditions in "Maryland Oncology Hematology" are
"Cancer" (1 trials), "Early Detection of Cancer" (1 trials) and "SARS-CoV-2 Infection" (1 trials). Many other conditions were trialed in "Maryland Oncology Hematology" in a lesser frequency.
Clinical Trials Intervention Types at Maryland Oncology Hematology
Most popular intervention types in "Maryland Oncology Hematology" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Evusheld (tixagevimab+cilgavimab) IM or IV" (1 trials) and "Multi-Cancer Early Detection Test" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Maryland Oncology Hematology
The vast majority of trials in "Maryland Oncology Hematology" are
2 trials for "All" genders.
Clinical Trials Status at Maryland Oncology Hematology
Currently, there are NaN active trials in "Maryland Oncology Hematology".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Maryland Oncology Hematology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Maryland Oncology Hematology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".